Research
-
Investigating the use of Benzophenones for the treatment of Oculocutaneous Albinism type 1 (OCA1)
ActiveFebruary 2025 - January 2026 -
Targeting members of the IgLON family as a novel and translatable approach to promote neuroprotection and nerve repair
ActiveFebruary 2025 - January 2026 -
Preoperative host imaging markers of outcome following Descemet Membrane Endothelial Keratoplasty
ActiveFebruary 2025 - November 2025 -
Applying AI to screening for Birdshot Chorioretinopathy and predicting response to treatment
ActiveMarch 2025 - February 2026 -
Retinal Specific Oligonucleotide Development Through Chemical Modification
ActiveFebruary 2025 - February 2026 -
Optimisation of cell specific, dual vector delivery for CRB1-associated inherited retinal degeneration.
ActiveFebruary 2025 - January 2026 -
Feasibility of mindfulness visualisation to treat visual hypersensitivity
ActiveFebruary 2025 - January 2026